Clinical Trial Update: Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and tumoricidal effect of low-dose Foscan PDT in inoperable bile duct cancers (cholangiocarcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Foscan PDT (meso-tetrahydroxyphenyl chlorin (Foscan))

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Cholangiocarcinoma, Tumor | Phase 2 | Status: COMPLETED